Tourangeau Greg 4
4 · Fulcrum Therapeutics, Inc. · Filed Jul 19, 2022
Insider Transaction Report
Form 4
Tourangeau Greg
Principal Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2022-07-15+16,540→ 16,540 totalExercise: $5.39Exp: 2032-07-14→ Common Stock (16,540 underlying)
Footnotes (1)
- [F1]This option was granted on July 15, 2022 and is is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of July 1, 2022, subject to the reporting person's continued service on each such vesting date.